"Disruption of hepatic IL-1 signaling improves insulin sensitivity and hepatic inflammation in a model of non-alcoholic fatty liver disease (NAFLD)"

Poster presentation given by UMC at the 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Washington DC, USA, 20th - 24th October 2017

"Bimodal Targeted Near Infrared/Positron Emission Tomography Contrast Agent to Image Liver Fibrogenesis"

Poster presentation given by UMC at the 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Washington DC, USA, 20th - 24th October 2017

"Glucagon-like peptide-1 receptor agonists inhibit inflammatory macrophage activation and improve the major components of NASH in an optimized CDAA mouse model"

Poster presentation given by UMC at the 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Washington DC, USA, 20th - 24th October 2017

"A mouse model with inducible ablation of TGFβ receptor type 2 limited to hepatic stellate cells predicts the power of HSC-specific TGFβ pathway inhibition"

Poster presentation given by UMC at the 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Washington DC, USA, 20th - 24th October 2017

"Insulin secretion and decreased glucose clearance are associated with enhanced fibrogenesis and a high risk of disease progression in non-diabetic patients with Non Alcoholic Fatty Liver Disease"

Poster presentation given by UNEW, UNITO, CNR, UMC & NB at the 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Washington DC, USA, 20th - 24th October 2017

"High-throughput RNA sequencing on liver biopsy material stratifies patients with non-alcoholic fatty liver disease"

Poster presentation given by UNEW, UCAM, ICAN, UNITO & UMC at the 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Washington DC, USA, 20th - 24th October 2017

Lecture given by UNEW at the 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Washington DC, USA, 20th - 24th October 2017

"Development and Validation of the Collagen Neo-Epitope Biomarker Pro-C3 ‘FIB-C3 Score’ for Detection and Staging of Advanced Non-Alcoholic Fatty Liver Disease in a Large International Multi-Centre Patient Cohort"

Oral presentation given by UNEW, ICAN, UNITO, UMC & NB at the 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Washington DC, USA, 20th - 24th October 2017

Oral presentation given by CNR at the Meeting Quadrisocietario Diabesità (SICOB, SID, SIE, SIO), Pisa, Italy, 5th - 6th October 2017

"Fatty liver disease is associated to increased glucogenic amino acids and decreased de novo alanine synthesis"

Oral presentation given by CNR & UNITO at the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD 2017), Lisbon, Portugal, 15th September 2017